Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
Cognitive impairment is a common symptom in individuals with Multiple Sclerosis (MS), but meaningful, reliable biomarkers relating to cognitive decline have been elusive, making evaluation of the impact of therapeutics on cognitive function difficult. Here, we combine pathway-based MRI measures of s...
Main Authors: | Katherine A Koenig, Erik B Beall, Ken E Sakaie, Daniel Ontaneda, Lael Stone, Stephen M Rao, Kunio Nakamura, Stephen E Jones, Mark J Lowe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0251338 |
Similar Items
-
Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
by: Sibaji Gaj, et al.
Published: (2021-01-01) -
Low consistency of four brain connectivity measures derived from intracranial electrode measurements
by: Stephen Edward Jones, et al.
Published: (2014-12-01) -
Thalamic Injury and Cognition in Multiple Sclerosis
by: Moein Amin, et al.
Published: (2021-02-01) -
Management of acute exacerbations in multiple sclerosis
by: Ontaneda Daniel, et al.
Published: (2009-01-01) -
Radial diffusivity reflects general decline rather than specific cognitive deterioration in multiple sclerosis
by: Johan Baijot, et al.
Published: (2022-12-01)